BF Biosciences launches human insulin 'Ferulin'

MG News | August 15, 2024 at 11:11 AM GMT+05:00

0:00

August 15, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ) has successfully launched human insulin under the brand name "Ferulin", the company's filing on PSX revealed.

This launch marks a significant milestone in our commitment to STOP DIABETES, expand our product portfolio and enhance the availability of life-saving medicines in the market.

Ferulin has been developed with the highest quality standards and is intended to provide effective and affordable diabetes treatment to patients across Pakistan.

Being the 1st Biotech Plant in Pakistan, BF Biosciences Limited has been committed to the production of essential medicines for the treatment of HCV, Cancer, Cardiology and other therapeutic areas for over a decade.

The company is confident that Ferulin will positively impact the subsidiary's growth and will further strengthen its mission to address unmet patient needs.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	157,953.47 555.47M	1.14% 1775.65
ALLSHR	96,741.22 1,957.60M	1.16% 1110.83
KSE30	48,198.94 249.79M	1.09% 520.47
KMI30	232,694.17 290.89M	1.31% 3011.94
KMIALLSHR	65,027.13 1,019.78M	1.03% 660.37
BKTi	42,489.56 84.10M	1.35% 566.75
OGTi	31,779.36 15.21M	0.14% 43.57

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	117,405.00	118,295.00 116,115.00	1580.00 1.36%
BRENT CRUDE	68.01	68.16 67.34	0.06 0.09%
RICHARDS BAY COAL MONTHLY	84.00	0.00 0.00	-0.40 -0.47%
ROTTERDAM COAL MONTHLY	94.50	94.50 94.50	0.95 1.02%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	63.76	63.91 63.11	0.06 0.09%
SUGAR #11 WORLD	16.15	16.27 16.13	-0.12 -0.74%